GreenLight Biosciences Holdings Pbc operates as a pre-commercial-stage biotechnology company. It provides a cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company’s plant and animal health pipeline includes Calantha for the Colorado potato beetle; Varroa mites, an RNA-based syrup that targets reproductive mites; Vegetable Caterpillar Complex, an dsRNA-based pesticide for the Diamond Back Moth; and Spider Mite Complex for the control of Tetranychus urticae. It is also developing fungicide program for botrytis, fusarium, powdery mildew, downy mildew, Asian soybean rust, and rice blast; Gray Mold + for botrytis cinerea; Powdery mildew complex for the control of powdery mildew, caused by Erysiphe necator; and Mycotoxin control for Fusarium Head Blight, a cereal crop-based disease. In addition, the company also develops a human health program comprising a phase I/II preclinical stage vaccine for COVID-19 and candidate selection vaccines for shingles and oncology. Greenlight Biosciences Holdings Pbc was formerly known as GreenLight Biosciences, Inc. and changed its name to Greenlight Biosciences Holdings Pbc in February 2022. The company was founded in 2008 and is based in Lexington, Massachusetts.